Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Completed Initiated Jul 2, 2019 (7 years ago)

Ofloxacin Ophthalmic Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05

Affected NDC 59390-0140-05

Compare with the code on your package — it is the most precise check available.

Drug: Ofloxacin Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Ofloxacin ophthalmic
Ofloxacin
NDC 59390-0140
3 mg/mL Solution
Ophthalmic
Altaire Pharmaceuticals Inc. Rx
Recalling firm
Altaire Pharmaceuticals, Inc.
NDC code
59390-140-05
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0436-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ofloxacin recalls

See all

Other recalls by Altaire Pharmaceuticals, Inc.

All 2019 recalls